BlackRock Japan’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,642
Closed -$45K 1416
2014
Q4
$45K Sell
1,642
-3,999
-71% -$99.1K ﹤0.01% 1114
2014
Q3
$126K Buy
+5,641
New +$143K ﹤0.01% 909
2014
Q2
Sell
-11,046
Closed -$314K 1451
2014
Q1
$314K Sell
11,046
-6,911
-38% -$229K ﹤0.01% 848
2013
Q4
$693K Sell
17,957
-3,625
-17% -$130K ﹤0.01% 741
2013
Q3
$723K Sell
21,582
-10,963
-34% -$349K ﹤0.01% 717
2013
Q2
$1M Buy
+32,545
New +$1.09M ﹤0.01% 679

Other funds holding MDCO

BlackRock Japan's MDCO Position: Q1 2015 in Review

BlackRock Japan sold out of Medicines Co (MDCO) in Q1 2015, closing a stake of 1,642 shares — an estimated $45K sold.

BlackRock Japan first reported a position in MDCO in Q2 2013 and held it in 6 quarters. The position peaked at $1M in Q2 2013. 184 funds tracked by Wall St. Rank hold MDCO as of Q1 2015.

  • BlackRock Japan reported no remaining Medicines Co position as of Q1 2015 after selling out during the quarter.
  • BlackRock Japan sold 1,642 Medicines Co shares in Q1 2015, an estimated $45K.
  • BlackRock Japan first reported a position in Medicines Co in Q2 2013 and held it in 6 quarters.
  • BlackRock Japan's Medicines Co position peaked at $1M in Q2 2013.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q1 2015.

Based on BlackRock Japan's 13F filing for Q1 2015, filed 13 May 2015.